Paradigm Medical Industries Inc. (PDMI)

[mike306oh]

Re: OS is 52.96 MM (according to UKCop.com). See below.

Also, a bounch of other alerts on PMED yesterday and today:

*Stockguru.com: Guru Alerts for Tuesday, January 31, 2006 OGHC, SUWN, TREN, PMED.
Jan 31 2006 10:16AM ET

*OTCPicks.com: Daily Market Movers Digest Midday Stock Alerts, Monday, January 30th, CTBG, PECB, PMED, CLRI, EPHM, BIGN
Jan 30 2006 1:13PM ET

*UKCap.com: Initiates Profile on Paradigm Medical Industries, Inc. (OTCBB: PMED) for Monday January 30, 2006.
Jan 30 2006 12:00PM ET

*Stockwire.com: The Movers and Shakers Blog, Part 3:
Jan 30 2006 11:27AM ET

*BUYINS.NET: TNOG, ACUP, ENDO, IMDS, MMIO, PMED have also been added to naked short lists today
Jan 30 2006 10:47AM ET

See:

http://www.pinksheets.com/quote/news.jsp?symbol=PMED

COMPANY NEWS AND PRESS RELEASES FROM OTHER SOURCES:

UKCap.com: Initiates Profile on Paradigm Medical Industries, Inc. (OTCBB: PMED) for Monday January 30, 2006.

Jan 30, 2006 (M2 PRESSWIRE via COMTEX) -- Sign-up for our FREE Stock Alerts at http://www.UKCap.com!
UKCap.com strives to find dynamic issues that are unknown or undervalued but because of their technology, approach, executive team, recent discoveries or other key factors, could advance in the market. UKCap.com has identified the following company based on these issues: ViRexx Paradigm Medical Industries, Inc. (OTCBB: PMED) up 43.64% with 4,979,886 shares trading hands this morning.

Chart: http://www.smallcapusa.com/site/symbol_chart.php?symbol=pmed.ob

Paradigm Medical Industries, Inc. (OTCBB: PMED) engages in the development and marketing of diagnostic equipment for the ophthalmic market. Its product families of topographers, autoperimeters, and ultrasonic biomicroscopes combined with its Blood Flow Analyzer help the eye care professionals community diagnose and treat disorders of the eye, such as glaucoma, cataracts, and age-related macular degeneration. Its products include LD400, a voice-based, affordable, computer autoperimeter capable of threshold, fast threshold, and suprathreshold testing; CT200E, a computer-based corneal topographer with output for contact lens fitting, as well as pre and post refractive surgical measurements; Ocular Blood Flow Analyzer, a tonometer designed to measure intraocular pressure and sensitive enough to detect pulsatile blood flow; P37 A-B Scan, an ultrasonic A and B Scan for biometry and imaging of the retina; P40, an ultrasonic biomicroscope; P45, an ultrasonic biomicroscope with A and B Scan capabilities in addition to 35 MHz; and P60, an ultrasonic biomicroscope with sulcus-to-sulcus imaging and self-contained water path probe. It markets its products through direct sales representatives, independent sales representatives, and ophthalmic product distributors in the United States, as well as internationally through a network of dealers. The company was founded by Thomas F. Motter and Robert W. Millar in 1989 and is headquartered in Salt Lake City, Utah. With 52.96 million shares outstanding and an undisclosed short position, there is a failure to deliver in shares of PMED

To chat with other investors on this company visit http://www.smallcapcommunity.com "SmallCap Community is a rapidly growing community of investors looking to network, meet new people, exchange ideas, and make smarter investments!"

COMMENTARY:

Stocks showing interesting activity Friday at the close of the regular trading day were: SIRIUS Satellite Radio (NASDAQ: SIRI) up 0.8% on 47.5 million shares traded, Broadcom Corp. (NASDAQ: BRCM) up 18.9% on 43.4 million shares traded and Time Warner (NYSE: TWX) up 1% on 22.1 million shares traded.

ABOUT UKCap.com

UKCap.com is a leading investor relations firm whose primary focus is promoting awareness among brokers, investors, and others in the investment community who are interested in small and micro-cap companies. UKCap.com is dedicated to helping publicly traded companies gain the exposure they need to move forward with the development of their business plans. UKCap's goal is to feature equity investments in micro or small capitalization companies that have the potential for long-term appreciation. Our web site features companies in Profile. We publish a Newsletter to subscribers, and we publish our Newsletter, Profile or Mid-Day Stock Alert which is sent out on the M2 Presswire several times daily highlighting hot OTC and OTCBB stocks. To subscribe or get more information, visit our home page located at http://www.UKCap.com/index.htm .

We offer many investor relations programs to public companies. To feature a company on our web site or in our daily Newsletter or Mid-Day Stock Alert, please contact David Brooks via email at [e-mail].

UKCap.com based upon information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by UKCap.com to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. Learn more at http://www.ukcap.com/glossary.htm This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. UKCap.com is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.UKCap.com or mentioned herein. UKCap.com has not been compensated by any of the companies mentioned in this opinion. UKCap's affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event of a rise in value. UKCap.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market. To view full disclaimers, go to http://www.UKCap.com/disclaimer.htm.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and UKCap.com undertakes no obligation to update such statements.

Archived at: http://www.ukcap.com/news/497.htm

SPONSORED BY: http://www.choicerx.biz . Proud to be able to bring you our wide selection of medicines, all of them are available to you online, 24x7. No Waiting for Doctors, you will enjoy complete privacy, and you can order anytime, in your own time, with No prior prescription needed!

CONTACT: David Brooks e-mail: [e-mail]

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to [e-mail].